In the BRCA mutation carrier setting, cell ‘non-autonomous' factors such as aberrant levels and/or dynamics of cytokines released from the ovary during the repair of the ovarian surface after each monthly ovulation, which affect the fimbriae in a paracrine fashion, or a higher rate of ascending infections, may drive cancer predisposing aberrant AID expression. This evidence concerns the gene AICDA and cancer.